RVPH
HealthcareReviva Pharmaceuticals Holdings, Inc.
$0.33
+$0.02 (+6.45%)
Jan 5, 2026
Price History (1Y)
Analysis
Reviva Pharmaceuticals Holdings, Inc. is a healthcare company operating in the biotechnology industry. The company has 14 employees and a market capitalization of $69.59 million. The financial information for Reviva Pharmaceuticals Holdings, Inc. is not available as the necessary metrics are listed as N/A. This indicates that the data is either not provided or not applicable to the company's current situation. There is no available valuation context information for Reviva Pharmaceuticals Holdings, Inc., including P/E ratios, growth rates, and dividend yield, as all these metrics are also listed as N/A. The 52-week high and low prices for the company's stock are $2.17 and $0.25, respectively, with a beta of -0.03.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
Visit website →Key Statistics
- Market Cap
- $69.59M
- P/E Ratio
- N/A
- 52-Week High
- $2.17
- 52-Week Low
- $0.25
- Avg Volume
- 10.12M
- Beta
- -0.03
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 14